Study of Retinopathy of Prematurity in Neonates With Unstable Clinical Course
Keywords:
Retinopathy of Prematurity, Neonatal Screening, Risk Factors, Preterm InfantsAbstract
Background: Retinopathy of Prematurity (ROP) is a major contributor to blindness in children, especially affecting infants born prematurely. Timely identification and treatment are essential to avert permanent vision impairment. Although neonatal care has improved, ROP continues to pose a worldwide health challenge, highlighting the need for screening and awareness of risk factors.
Aim & Objectives: The objective of this study is to identify the risk factors and clinical characteristics of ROP in preterm infants at a tertiary care facility. Specific objectives include assessing the severity of ROP and its progression through follow-up evaluations.
Material and Methods: This prospective, hospital-based research was carried out over a period of 18 months and involved 100 preterm infants, each with a gestational age of less than 37 weeks and a birth weight under 2 kg. Ophthalmic examinations were performed using binocular indirect ophthalmoscopy, and data were analyzed statistically to assess associations with risk factors.
Results: Most infants were examined between 2 to 6 weeks of age, predominantly low birth weights, between 1 and 1.5 kg, born between 32 and 36 weeks gestation with risk factors such as respiratory distress and sepsis. At initial screening, 85% showed normal retinas, while 10% had Stage 1 ROP, 4% had Stage 2-3, and 1% had Stage 3+ with retinal detachment. After four weeks, 93% had normal retina, with no infants at Stage 1; two infants progressed to Stage 2. Statistical analysis showed no significant associations between most risk factors and severity.
Conclusion: Early screening is vital in managing ROP, especially in high-risk preterm infants. The multifactorial nature of ROP underscores the need for vigilant monitoring and further research to optimize prevention and treatment strategies
Downloads
Metrics
References
Hellström A, Smith LE, Dammann O: Retinopathy of prematurity. Lancet. 2013, 382:1445-57. 10.1016/S0140-6736(13)60178-6.
Kayton A, Timoney P, Vargo L, Perez JA: A review of oxygen physiology and appropriate management of oxygen levels in premature neonates. Adv Neonatal Care. 2018, 18:98-104. 10.1097/ANC.0000000000000434.
Sabri K, Ells A, Lee EY, et al. Retinopathy of Prematurity: A Global Perspective and Recent Developments. Pediatrics. 2022;150(3):e2021053924.
Jefferies A: Retinopathy of prematurity: recommendations for screening. Paediatr Child Health. 2010, 15:667-74. 10.1093/pch/15.10.667.
Fierson WM: Screening examination of premature infants for retinopathy of prematurity . Pediatrics. 2013, 131:189-95. 10.1542/peds.2012-2996.
Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013 Dec;74 Suppl 1(Suppl 1):35-49. [PMC free article] [PubMed] [Reference list]
Essex RW, Carden SM, Elder JE. Two-year results of laser treatment for retinopathy of prematurity at a single neonatal intensive care unit. Clin Exp Ophthalmol. 2005 Aug;33(4):390-4. [PubMed] [Reference list]
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018 Sep-Oct;63(5):618-637. doi: 10.1016/j.survophthal.2018.04.002. Epub 2018 Apr 19. PMID: 29679617; PMCID: PMC6089661.
Tapak, L., Farahani, L.N., Taleghani, N.T. et al. Risk factors for the time to development of retinopathy of prematurity in premature infants in Iran: a machine learning approach. BMC Ophthalmol 24, 364 (2024). https://doi.org/10.1186/s12886-024-03637-w
Yucel, O.E., Eraydin, B., Niyaz, L. et al. Incidence and risk factors for retinopathy of prematurity in premature, extremely low birth weight and extremely low gestational age infants. BMC Ophthalmol 22, 367 (2022). https://doi.org/10.1186/s12886-022-02591-9
Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233-48; discussion 248-50. PMID: 15747762; PMCID: PMC1280104.
Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, Hardy RJ, Phelps DL, Baker JD, Trese MT, Schaffer D, Tung B; CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol. 2002 Nov;120(11):1470-6. doi: 10.1001/archopht.120.11.1470. PMID: 12427059.
Tang W, Zhang Y, Zhang H, Li K, Zhao Z, Ma H, Jiang X, Jia Z, Ma Q. Progress in the study of association between hematological indicators and retinopathy of prematurity (Review). Biomed Rep. 2024;21(2):111.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
